BamaCrazy
Member
Odd. The study was conducted 2014-2015 and the findings were published 2017. And the Quartet Project began in 2016. They did another study 2017-2020. Then a systematic review and meta analysis in 2023. But it does not look like it’s being adopted anywhere.We're about to see ultra-low dose quad pills. The most impressive thing with the trials so far, no subjects have experienced any side effects typically associated with bp meds, and 100% get significant reductions in blood pressure.
It looks like these may become first line therapy for hypertension.
![]()
Less is more: potential breakthrough for treating hypertension with ultra low-dose combinations | The George Institute for Global Health
Professor Clara Chow, of The George Institute, said the results published in The Lancet were exciting but larger trials were needed to see if these high rates could be maintained and repeated.www.georgeinstitute.org